Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
Price Target
Average
22.60%
Revenue Forecast
Estimate
33.01%
EBIT
Estimate
--121.98%
Net Income
Estimate
70.04%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Alnylam Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for ALNY of $298 , with forecasts ranging from
a
low of
$234 to a high of $400 .
ALNY Lowest Price Target
Wall Street Target
234 USD
-3.84%
ALNY Average Price Target
Wall Street Target
298 USD
22.60%
ALNY Highest Price Target
Wall Street Target
400 USD
64.38%
REVENUE FORECAST
Revenue Forecast Chart ALNY
EBIT FORECAST
EBIT Forecast Chart ALNY
NET INCOME FORECAST
Net Income Chart ALNY